MGLN Magellan Health
Magellan Health, Inc. engages in the business of healthcare management. It operates through the following segments: Healthcare, Pharmacy Management and Corporate. The Healthcare segment comprises of the Commercial and Government reporting units. The Pharmacy Management segment offers products and solutions that provide clinical and financial management of pharmaceuticals paid under both the medical and the pharmacy benefit. The Corporate segment covers amounts not allocated to the Healthcare and Pharmacy Management segments. The company was founded in 1969 and is headquartered in Phoenix, AZ.
Company profile
Ticker
MGLN
Exchange
Website
CEO
Kenneth J. Fasola
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
CHARTER MEDICAL CORP, MAGELLAN HEALTH SERVICES INC
SEC CIK
Corporate docs
IRS number
581076937
MGLN stock data
()
Press releases
Magellan Rx Management Oncology Biosimilar Solution Delivers $40M+ in Annualized Savings for Early Adopter Health Plans
9 Jun 21
Magellan Rx Management's Medical Pharmacy Trend Report Unlocks the Latest Trends and Emerging Strategies to Manage Rising Medical Benefit Specialty Drug Spend
20 May 21
Mightier Video Game Pilot Program with Magellan Healthcare Leads to 45% Improvement in Symptoms for Children with Autism
11 May 21
Magellan Health Reports First Quarter 2021 Financial Results
30 Apr 21
Magellan Healthcare Provides Vital Resources for Adults and Youth During Mental Health Month
20 Apr 21
Calendar
30 Apr 21
14 Jun 21
31 Dec 21
Financial summary
Quarter (USD) |
Mar 21 | Dec 20 | Sep 20 | Jun 20 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
Annual (USD) |
Dec 20 | Dec 19 | Dec 18 | Dec 17 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
Financial data from company earnings reports.
| Cash burn rate (estimated) | Burn method: Change in cash | Burn method: Operating income/loss | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 456.31M | 456.31M | 456.31M | 456.31M | 456.31M | 456.31M |
| Cash burn (monthly) | 229.38M | (positive/no burn) | (positive/no burn) | 480.25K | 25.96M | (positive/no burn) |
| Cash used (since last report) | 565.98M | n/a | n/a | 1.18M | 64.05M | n/a |
| Cash remaining | -109.67M | n/a | n/a | 455.12M | 392.26M | n/a |
| Runway (months of cash) | -0.5 | n/a | n/a | 947.7 | 15.1 | n/a |
Recent insider trades
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 5 Mar 21 | Jeffrey N West | Ordinary Common Stock, $0.01 par value | Payment of exercise | Dispose F | No | No | 93.29 | 677 | 63.16K | 25,692 |
| 5 Mar 21 | Jeffrey N West | Ordinary Common Stock, $0.01 par value | Option exercise | Aquire M | No | No | 0 | 1,447 | 0 | 26,369 |
| 5 Mar 21 | Jeffrey N West | Ordinary Common Stock, $0.01 par value | Option exercise | Aquire M | No | No | 0 | 839 | 0 | 24,922 |
| 5 Mar 21 | Jeffrey N West | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 1,447 | 0 | 1,447 |
| 5 Mar 21 | Jeffrey N West | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 839 | 0 | 0 |
| 4 Mar 21 | Kenneth J Fasola | Ordinary Common Stock, $0.01 par value | Payment of exercise | Dispose F | No | No | 93.47 | 4,366 | 408.09K | 11,937 |
| 4 Mar 21 | Kenneth J Fasola | Ordinary Common Stock, $0.01 par value | Option exercise | Aquire M | No | No | 0 | 11,099 | 0 | 16,303 |
| 4 Mar 21 | Kenneth J Fasola | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 11,099 | 0 | 22,196 |
| 4 Mar 21 | Clapper Caskie Lewis | Ordinary Common Stock, $0.01 par value | Payment of exercise | Dispose F | No | No | 93.47 | 1,109 | 103.66K | 24,195 |
| 4 Mar 21 | Clapper Caskie Lewis | Ordinary Common Stock, $0.01 par value | Option exercise | Aquire M | No | No | 0 | 2,435 | 0 | 25,304 |
Institutional ownership Q1 2021
Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.
96.5% owned by funds/institutions
13F holders |
Current |
|---|---|
| Total holders | 182 |
| Opened positions | 44 |
| Closed positions | 49 |
| Increased positions | 55 |
| Reduced positions | 59 |
13F shares |
Current |
|---|---|
| Total value | 4.7B |
| Total shares | 25.24M |
| Total puts | 23.6K |
| Total calls | 16K |
| Total put/call ratio | 1.5 |
Largest owners |
Shares | Value |
|---|---|---|
| BLK Blackrock | 3.8M | $354.54M |
| Vanguard | 2.48M | $231.56M |
| Starboard Value | 2.37M | $220.9M |
| Dimensional Fund Advisors | 1.71M | $159.38M |
| Magnetar Financial | 1.37M | $128.14M |
| STT State Street | 938.63K | $87.52M |
| Victory Capital Management | 920.99K | $85.87M |
| Segall Bryant & Hamill | 859.87K | $80.18M |
| Arp Americas | 757.74K | $70.65M |
| Alpine Associates Management | 687.29K | $64.08M |
Financial report summary
?Competition
CignaManagement Discussion
- Net revenue, cost of care, cost of goods sold, and direct service costs and other operating expense variances are addressed within the segment results that follow.
- Depreciation and amortization expense decreased by 10.9 percent or $12.0 million from 2019 to 2020, primarily due to asset maturities and office impairments, partially offset by normal asset additions in the current year.
- Interest expense decreased by $5.0 million from 2019 to 2020 primarily due to lower interest rates and lower debt balances.
Content analysis
?
| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. freshman Bad
|
|
New words:
advance, American, assumption, attract, Aurelia, Bella, canceled, Centene, Chancery, converted, deduction, delay, EBITDA, exclusive, forum, greater, half, judicial, LLC, matter, Mayflower, mezzanine, Michael, proceeding, proxy, pursue, put, receipt, Rescue, retention, stranded, surviving, trailing, viewed, Vista
Removed:
ABD, absence, acceptable, accrue, accuracy, accurate, achieve, acute, adequately, aged, agreed, AlphaCare, alternative, announcement, annually, Antitrust, approaching, arise, assumed, attack, attempting, attention, attrition, award, began, blind, breakdown, Carlo, carve, CCC, Code, commitment, committee, Commonwealth, compensate, comprise, confidentiality, considerable, consummation, contingency, continued, Coordinated, country, cyber, damage, declared, degree, delegate, detective, difficult, disabled, disruption, diversion, dividend, dividing, driver, effectively, eliminate, employ, ending, enhancement, enhancing, entering, entitle, error, estimating, evaluate, evolving, exfiltration, expiration, exposure, expressed, fail, finalized, fluctuation, forecast, forecasted, forensic, free, gaining, GDPR, global, governing, granted, grantee, grow, growth, harmed, hold, human, identify, impacting, implement, incident, incorporate, increasingly, incurred, indemnification, indemnified, instituted, integrate, intending, international, interruption, investigating, IRS, legislation, life, lost, maintenance, malfeasance, materiality, Medallion, minimize, misplaced, Monte, moratorium, negatively, notifying, obtaining, operate, outage, outbreak, oversee, PDP, peer, pendency, penetrating, percentile, perform, performed, phishing, pool, positive, preceding, predicted, prediction, preventive, programming, prohibiting, proliferation, proprietary, protect, prove, quantifiable, quantified, ranking, ransomware, rapidly, recent, recently, recession, recoupment, regular, regulate, reinvestment, relevant, reliably, renewed, response, rest, resumption, retroactive, routine, routinely, satisfactory, SCO, score, securely, separation, settlement, significantly, simulation, SMI, spread, store, strategic, strategically, successfully, suffered, suspending, SWH, system, target, test, testing, transitioning, transmit, turn, ultimately, unable, unexpected, unsuccessful, unused, upgrade, vandalism, vendor, vesting, volatility, vulnerable, waiting, wide, widely, work, world, York
Financial reports
10-Q
2021 Q1
Quarterly report
30 Apr 21
10-K/A
2020 FY
Annual report (amended)
29 Apr 21
10-K
2020 FY
Annual report
25 Feb 21
10-Q
2020 Q3
Quarterly report
29 Oct 20
10-Q
2020 Q2
Quarterly report
29 Jul 20
10-Q
2020 Q1
Quarterly report
11 May 20
10-K
2019 FY
Annual report
28 Feb 20
10-Q
2019 Q3
Quarterly report
1 Nov 19
10-Q
2019 Q2
Quarterly report
30 Jul 19
10-Q
2019 Q1
Quarterly report
2 May 19
Current reports
8-K
Magellan Health Reports First Quarter 2021 Financial Results
30 Apr 21
8-K
Submission of Matters to a Vote of Security Holders
31 Mar 21
8-K
Other Events
19 Mar 21
8-K
Magellan Health Reports 2020 Financial Results
26 Feb 21
8-K/A
Financial Statements and Exhibits
6 Jan 21
8-K
Ken Fasola’s Employee Announcement Email
4 Jan 21
8-K
Centene Signs Definitive Agreement to Acquire Magellan Health
4 Jan 21
8-K
Centene Signs Definitive Agreement to Acquire Magellan Health
4 Jan 21
8-K
Completion of Acquisition or Disposition of Assets
4 Jan 21
8-K
Magellan Health Reschedules Third Quarter 2020 Earnings Conference Call
29 Oct 20
Registration and prospectus
S-8
Registration of securities for employees
11 Jun 18
424B2
Prospectus for primary offering
17 Sep 17
424B2
Prospectus for primary offering
14 Sep 17
FWP
Free writing prospectus
14 Sep 17
S-3ASR
Automatic shelf registration
30 Aug 17
S-8
Registration of securities for employees
28 Jul 16
S-8
Registration of securities for employees
2 Jun 14
S-8
Registration of securities for employees
17 May 11
S-8
Registration of securities for employees
17 May 11
S-8
Registration of securities for employees
20 May 08
Proxies
DEFA14A
Additional proxy soliciting materials
19 Mar 21
DEFM14A
Proxy related to merger
19 Feb 21
PREM14A
Preliminary proxy related to merger
8 Feb 21
DEFA14A
Additional proxy soliciting materials
4 Jan 21
DFAN14A
Additional proxy materials by non-management
4 Jan 21
DEFA14A
Additional proxy soliciting materials
4 Jan 21
DEFA14A
Additional proxy soliciting materials
4 Jan 21
DEFA14A
Additional proxy soliciting materials
4 Jan 21
DEFA14A
Additional proxy soliciting materials
2 Jun 20
DEF 14A
Definitive proxy
29 Apr 20
Other
UPLOAD
Letter from SEC
29 May 17
CORRESP
Correspondence with SEC
18 May 17
UPLOAD
Letter from SEC
9 May 17
UPLOAD
Letter from SEC
31 Aug 16
CORRESP
Correspondence with SEC
28 Aug 16
CT ORDER
Confidential treatment order
22 Aug 16
UPLOAD
Letter from SEC
1 Aug 16
UPLOAD
Letter from SEC
9 Sep 15
CORRESP
Correspondence with SEC
10 Aug 15
UPLOAD
Letter from SEC
30 Jul 15
Ownership
SC 13D/A
MAGELLAN HEALTH / Magnetar Financial ownership change
27 Apr 21
4
MAGELLAN HEALTH / JEFFREY N WEST ownership change
8 Mar 21
4
MAGELLAN HEALTH / David Bourdon ownership change
5 Mar 21
4
MAGELLAN HEALTH / Mostafa Kamal ownership change
5 Mar 21
4
MAGELLAN HEALTH / JEFFREY N WEST ownership change
5 Mar 21
4
MAGELLAN HEALTH / JAMES E MURRAY ownership change
5 Mar 21
4
MAGELLAN HEALTH / Clapper Caskie Lewis ownership change
5 Mar 21
4
MAGELLAN HEALTH / KENNETH J FASOLA ownership change
5 Mar 21
4
MAGELLAN HEALTH / David Haddock ownership change
4 Mar 21
SC 13G/A
MAGELLAN HEALTH / DIMENSIONAL FUND ADVISORS ownership change
11 Feb 21
Transcripts
2020 Q3
Earnings call transcript
31 Oct 20
2020 Q2
Earnings call transcript
29 Jul 20
2020 Q1
Earnings call transcript
11 May 20
2019 Q4
Earnings call transcript
28 Feb 20
2019 Q3
Earnings call transcript
1 Nov 19
2019 Q2
Earnings call transcript
30 Jul 19
2019 Q1
Earnings call transcript
5 May 19
2018 Q4
Earnings call transcript
28 Feb 19
2018 Q3
Earnings call transcript
10 Nov 18
2018 Q2
Earnings call transcript
27 Jul 18